Transcend Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
6,283
+661
+12% +$32.2K 0.02% 581
2026
Q1
$241K Sell
5,622
-2,083
-27% -$89.6K 0.02% 619
2025
Q4
$338K Buy
+7,705
New +$319K 0.03% 491

Other funds holding EXEL

Transcend Capital Advisors's EXEL Position: Q2 2026 in Review

Transcend Capital Advisors increased its Exelixis (EXEL) stake by 12% in Q2 2026, buying an estimated $32.2K and bringing the position to 6,283 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #581.

Transcend Capital Advisors first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Transcend Capital Advisors held 6,283 shares of Exelixis worth $342K as of Q2 2026.
  • Transcend Capital Advisors bought 661 Exelixis shares in Q2 2026, an estimated $32.2K.
  • Exelixis made up 0.02% of Transcend Capital Advisors's portfolio in Q2 2026, its #581 holding.
  • Transcend Capital Advisors first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.